Second Attempt of Cabergoline Withdrawal in Patients with Prolactinomas after a Failed First Attempt: Is it Worthwhile?

Successful discontinuation of cabergoline (CAB) treatment has been reported in 31–75% of prolactinomas patients treated for at least 2 years. In contrast, it is not well established whether CAB therapy can be successfully withdrawn after a failed first attempt. This prospective open trial was design...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Endocrinol (Lausanne)
Main Authors: Vilar, Lucio, Albuquerque, José Luciano, Gadelha, Patrícia Sampaio, Rangel Filho, Frederico, Siqueira, Aline Maria C., da Fonseca, Maíra Melo, Viana, Karoline Frazão, Gomes, Barbara Sales, Lyra, Ruy
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2015
Assuntos:
Endocrinology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4316769/
https://ncbi.nlm.nih.gov/pubmed/25699020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2015.00011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados